[1]刘强瑞,刘宇峰,文 妮,等.醒脑静注射液联合脑苷肌肽注射液治疗高血压脑出血的临床疗效[J].国外医学医学地理杂志,2019,(02):161-163.[doi:10.3969/j.issn.1001-8883.2019.02.018]
　LIU Qiangrui,LIU Yufeng,WEN Ni,et al.Clinical effect of Xingnaojing injection combined with Brain GlycosidePeptide Injection on hypertensive cerebral hemorrhage[J].Foreign Medical Sciences (Section of Medgeography),2019,(02):161-163.[doi:10.3969/j.issn.1001-8883.2019.02.018]
点击复制

醒脑静注射液联合脑苷肌肽注射液治疗高血压脑出血的临床疗效()
分享到：

国外医学医学地理杂志[ISSN:1001-8883/CN:61-1102/R]

卷:
期数:
2019年02期
页码:
161-163
栏目:
临床医学
出版日期:
2019-07-02

文章信息/Info

Title:
Clinical effect of Xingnaojing injection combined with Brain GlycosidePeptide Injection on hypertensive cerebral hemorrhage
作者:
刘强瑞1; 刘宇峰2; 文 妮3; 王 萍4
(1.甘肃医学院附属医院神经内科,甘肃平凉 744000; 2.空军军医大学唐都医院神经外科,陕西西安 710000; 3.甘肃省平凉市人民医院中西医科,甘肃平凉 744000; 4.甘肃医学院附属医院护理系办公室,甘肃平凉 744000)
Author(s):
LIU Qiangrui1; LIU Yufeng2; WEN Ni3; WANG Ping4
(1.Department of neurology,affiliated hospital of Gansu Medical College,Pingliang,744000; 2.Department of neurosurgery,Tangdu hospital,Air Force Military Medical University,Xi’an 710000; 3.Department of Chinese and western medicine,People’s hospital of Pingliang,Pingliang 744000; 4.Department of nursing,affiliated hospital of Gansu Medical College,Pingliang 744000,China)
关键词:
醒脑静注射液;  脑苷肌肽注射液;  高血压脑出血;  水肿
Keywords:
xingnaojing injection;  brain glycoside peptide injection;  hypertensive intracerebral hemorrhage;  edema
分类号:
R554.1
DOI:
10.3969/j.issn.1001-8883.2019.02.018
文献标志码:
A
摘要:
目的 研究醒脑静注射液联合脑苷肌肽注射液治疗高血压脑出血的效果及对水肿的影响。方法 选择2018年1月—2019年1月甘肃医学院附属医院的100例高血压脑出血患者,随机分为两组。对照组采用脑苷肌肽注射液治疗,观察组采用醒脑静注射液联合脑苷肌肽注射液治疗。结果 观察组的总有效率明显高于对照组(P<0.05); 两组治疗后的NO和IGF-1水平明显升高(P<0.05),MIF水平明显降低(P<0.05),观察组更为明显(P<0.05); 两组治疗后的脑水肿和血肿体积明显降低(P<0.05),观察组更为明显(P<0.05)。结论 醒脑静注射液联合脑苷肌肽注射液能减轻高血压脑出血患者的脑水肿,提升IGF-1、NO水平,降低MIF水平。
Abstract:
Objective To study the effect of Xingnaojing Injection combined with Brain Glycoside Peptide Injection on hypertensive cerebral hemorrhage and its effect on edema.Methods Selected 100 patients with hypertensive cerebral hemorrhage who were treated in our hospital from Jan.2018 to Jan.2019,were randomly divided into two groups.The control group was treated with Brain Glycoside Peptide Injection,while the observation group was treated with Xingnaojing Injection combined with Brain Glycoside Peptide Injection.Results The total effective rate of the observation group was significantly higher than control group(P<0.05).After treatment,the levels of NO and IGF-1 were increased significantly(P<0.05),and the MIF level was decreased significantly(P<0.05),especially in the observation group(P<0.05),and the volume of brain edema and hematoma were decreased significantly(P<0.05),especially in the observation group(P<0.05).Conclusion Xingnaojing Injection combined with Brain Glycoside Peptide Injection can alleviate brain edema in patients with hypertensive intracerebral hemorrhage,increase the levels of IGF-1 and NO,and reduce the level of MIF,which is worthy of application and promotion.

参考文献/References:


[1] 汪奇柏,郑超,何建国,等.高血压脑出血的高危因素调查及应用研究[J].中国临床医生杂志,2017,45(1):50-53.
[2] 刘轶君,刘铸,关键.氨甲环酸注射液在防治高血压脑出血患者血肿再扩大中的应用[J].临床和实验医学杂志,2018,17(1):70-73.
[3] 孙凌云,张小强,王湘,等.高血压脑出血治疗中应用超早期小骨窗微创颅内血肿清除术的疗效分析[J].河北医学,2017,23(3):424-427.
[4] 全国脑血管病会议.脑卒中患者临床神经功能缺损程度评分标准[J].中华神经外科杂志,1996,29(6):382-384.
[5] 杨彦龙,常涛,郭少春,等.神经内镜下治疗幕上高血压脑出血[J].中华神经外科杂志,2017,33(7):733-735.
[6] 周维,杨立坚,李曦,等.神经节苷脂治疗微创颅内血肿清除术高血压脑出血的临床效果[J].中国医药导报,2017,14(5):79-82.
[7] 罗成军,王山,张召,等.三种手术方式治疗高血压脑出血的临床疗效比较[J].检验医学与临床,2017,14(20):2999-3002.
[8] 陈康宁,胡小兰,孙晓云,等.脑苷肌肽注射液治疗脑出血的系统评价与Meta分析[J].中国综合临床,2017,33(4):317-319.
[9] 向兴刚,安杨.中西医结合治疗急性期高血压脑出血的临床疗效观察[J].中西医结合心脑血管病杂志,2017,15(14):1707-1709.
[10] 靳冬.醒脑静注射液联合尿激酶治疗高血压脑出血的临床研究[J].现代药物与临床,2018,33(6):1342-1346.
[11] 王京娥,陈燕,高山,等.IGF-1、HMGB-1、GSN和MIF水平在高血压脑出血中的意义[J].河北医药,2016,38(18):2733-2736.
[12] 王冬梅,孙鼎明,陈洋.醒脑静注射液对大面积高血压脑出血术后患者NO、IGF-1水平的影响[J].当代医学,2018,24(26):97-99.

备注/Memo

备注/Memo:
收稿日期:2018-12-29 修回日期:2019-02-11
通信作者:王萍,副教授.
作者简介:刘强瑞(1974-),男(汉族),大学本科,副主任医师.研究方向:脑血管病.
更新日期/Last Update: 2019-07-02